CHRNA7 and hepatocellular carcinoma: To establish the correlation among liver α7nAChR activation, inhibition of inflammatory pathways and improvement in the insulin signalling, we used mouse hepatoma cell line treated with saturated fatty acid (SFA) in the presence or absence of pharmacological agonists of α7nAChR.